MX2019007040A - Composiciones, dispositivos, y métodos de prueba de sensibilidad para el trastorno de déficit de atención/trastorno de hiperactividad con déficit de atención (add/adhd). - Google Patents
Composiciones, dispositivos, y métodos de prueba de sensibilidad para el trastorno de déficit de atención/trastorno de hiperactividad con déficit de atención (add/adhd).Info
- Publication number
- MX2019007040A MX2019007040A MX2019007040A MX2019007040A MX2019007040A MX 2019007040 A MX2019007040 A MX 2019007040A MX 2019007040 A MX2019007040 A MX 2019007040A MX 2019007040 A MX2019007040 A MX 2019007040A MX 2019007040 A MX2019007040 A MX 2019007040A
- Authority
- MX
- Mexico
- Prior art keywords
- attention deficit
- value
- methods
- disorder
- compositions
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 230000035945 sensitivity Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 title 2
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 title 2
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 title 2
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 2
- 238000003149 assay kit Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/305—Attention deficit disorder; Hyperactivity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/02—Food
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- General Preparation And Processing Of Foods (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662434957P | 2016-12-15 | 2016-12-15 | |
| PCT/IB2017/058023 WO2018109746A1 (en) | 2016-12-15 | 2017-12-15 | Compositions, devices, and methods of attention deficit disorder/ attention deficit hyperactivity disorder (add/adhd) sensitivity testing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019007040A true MX2019007040A (es) | 2020-02-12 |
Family
ID=62558493
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019007040A MX2019007040A (es) | 2016-12-15 | 2017-12-15 | Composiciones, dispositivos, y métodos de prueba de sensibilidad para el trastorno de déficit de atención/trastorno de hiperactividad con déficit de atención (add/adhd). |
| MX2023005604A MX2023005604A (es) | 2016-12-15 | 2019-06-14 | Composiciones, dispositivos, y metodos de prueba de sensibilidad para el trastorno de deficit de atencion/trastorno de hiperactividad con deficit de atencion (add/adhd). |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023005604A MX2023005604A (es) | 2016-12-15 | 2019-06-14 | Composiciones, dispositivos, y metodos de prueba de sensibilidad para el trastorno de deficit de atencion/trastorno de hiperactividad con deficit de atencion (add/adhd). |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20200003769A1 (enExample) |
| EP (1) | EP3555616B1 (enExample) |
| JP (2) | JP2020502510A (enExample) |
| CN (2) | CN116047083A (enExample) |
| AU (2) | AU2017378442B2 (enExample) |
| CA (1) | CA3085431A1 (enExample) |
| MX (2) | MX2019007040A (enExample) |
| WO (1) | WO2018109746A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201705102QA (en) | 2014-11-14 | 2017-07-28 | Biomerica Inc | Compositions, devices, and methods of ibs sensitivity testing |
| CN109804247A (zh) | 2016-07-08 | 2019-05-24 | 拜尔梅里科有限公司 | 抑郁症敏感测试的组合物、设备以及方法 |
| JP2026049447A (ja) * | 2024-09-06 | 2026-03-18 | 国立大学法人金沢大学 | 牛乳アレルギー検査のためのデバイス、キット、及び方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0310522D0 (en) * | 2003-05-08 | 2003-06-11 | Yorktest Lab Ltd | Assay panel |
| US7252957B2 (en) * | 2004-02-03 | 2007-08-07 | Immunosciences Lab., Inc. | Identification of etiology of autism |
| WO2005078442A1 (en) * | 2004-02-10 | 2005-08-25 | Dantini Daniel C | Comprehensive food allergy test |
| US7601509B2 (en) * | 2004-07-15 | 2009-10-13 | Power Laura W | Biotype diets system: predicting food allergies by blood type |
| CN101109750A (zh) * | 2007-07-27 | 2008-01-23 | 杭州浙大生科生物技术有限公司 | 食物过敏原特异性IgG ELISA检测试剂盒及其制备方法 |
| WO2010009417A1 (en) * | 2008-07-17 | 2010-01-21 | John Shea | Method for testing and treating delayed food allergies |
| CN102341705B (zh) * | 2009-03-05 | 2015-08-19 | 味之素株式会社 | 克罗恩氏病诊断试剂 |
| US20150337349A1 (en) * | 2013-01-04 | 2015-11-26 | Second Genome, Inc. | Microbiome Modulation Index |
| SG11201705102QA (en) * | 2014-11-14 | 2017-07-28 | Biomerica Inc | Compositions, devices, and methods of ibs sensitivity testing |
| CN105785008A (zh) * | 2014-12-23 | 2016-07-20 | 北京新华联协和药业有限责任公司 | 一种食物不耐受检测试剂盒及其制备方法 |
-
2017
- 2017-12-15 CA CA3085431A patent/CA3085431A1/en active Pending
- 2017-12-15 JP JP2019531908A patent/JP2020502510A/ja active Pending
- 2017-12-15 WO PCT/IB2017/058023 patent/WO2018109746A1/en not_active Ceased
- 2017-12-15 CN CN202310151764.XA patent/CN116047083A/zh active Pending
- 2017-12-15 AU AU2017378442A patent/AU2017378442B2/en active Active
- 2017-12-15 CN CN201780085801.4A patent/CN110402390A/zh active Pending
- 2017-12-15 EP EP17880088.4A patent/EP3555616B1/en active Active
- 2017-12-15 MX MX2019007040A patent/MX2019007040A/es unknown
-
2019
- 2019-06-14 US US16/441,902 patent/US20200003769A1/en not_active Abandoned
- 2019-06-14 MX MX2023005604A patent/MX2023005604A/es unknown
-
2022
- 2022-10-21 JP JP2022168861A patent/JP7689378B2/ja active Active
-
2023
- 2023-01-19 AU AU2023200262A patent/AU2023200262A1/en not_active Abandoned
-
2025
- 2025-05-25 US US19/218,292 patent/US20260049980A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022183349A (ja) | 2022-12-08 |
| EP3555616A1 (en) | 2019-10-23 |
| MX2023005604A (es) | 2023-05-29 |
| CA3085431A1 (en) | 2018-06-21 |
| CN116047083A (zh) | 2023-05-02 |
| EP3555616C0 (en) | 2024-08-14 |
| WO2018109746A1 (en) | 2018-06-21 |
| AU2017378442A1 (en) | 2019-07-04 |
| JP2020502510A (ja) | 2020-01-23 |
| US20260049980A1 (en) | 2026-02-19 |
| AU2017378442B2 (en) | 2022-10-20 |
| CN110402390A (zh) | 2019-11-01 |
| JP7689378B2 (ja) | 2025-06-06 |
| US20200003769A1 (en) | 2020-01-02 |
| EP3555616B1 (en) | 2024-08-14 |
| AU2023200262A1 (en) | 2023-02-16 |
| EP3555616A4 (en) | 2020-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021009297A (es) | Composiciones, dispositivos, y metodos de pruebas de sensibilidad del ibs. | |
| BR112017007965A2 (pt) | método implantado por computador para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; aparelho para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; meio de armazenamento não transitório; programa de computador; kits para medir níveis de expressão de três ou mais genes-alvo da via de sinalização celular de tgf-b em uma amostra de um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; e uso do kit | |
| MX2016013959A (es) | Aparato y metodo para colorear pelo personalizado. | |
| EP4343788A3 (en) | Diagnostic methods | |
| EA201690465A1 (ru) | Способ оценки эффектов композиции, содержащей микроорганизмы, на кишечную микробиоту | |
| MX2023005604A (es) | Composiciones, dispositivos, y metodos de prueba de sensibilidad para el trastorno de deficit de atencion/trastorno de hiperactividad con deficit de atencion (add/adhd). | |
| WO2018007872A9 (en) | Biomarkers for inflammatory bowel disease | |
| EP3907509A3 (en) | Diagnosis of early stage pancreatic cancer | |
| WO2015193325A3 (en) | Ceramides and their use in diagnosing cvd | |
| MX2023005293A (es) | Composiciones, dispositivos y metodos de prueba de sensibilidad a la depresion. | |
| MX2023006660A (es) | Composiciones, dispositivos, y metodos de pruebas de sensibilidad a la osteoartritis. | |
| MX2018011166A (es) | Composiciones, dispositivos y metodos de prueba de sensibilidad de fibromialgia. | |
| AU2016250096A8 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features | |
| MX2024000466A (es) | Composiciones, dispositivos y metodos de pruebas de sensibilidad a la enfermedad de crohn. | |
| MX391844B (es) | Metodo y aparato para estimar la cantidad de microorganismos en una unidad taxonomica en una muestra. | |
| MX2018013120A (es) | Composiciones, dispositivos y metodos de prueba de sensibilidad a la colitis ulcerosa. | |
| MX2019003931A (es) | Metodo y sistema de analisis para analizar una muestra. | |
| WO2015166353A3 (en) | Early detection of preeclampsia | |
| MX2018007566A (es) | Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos de personas con dolor de cabeza por migraña. | |
| MX2018010856A (es) | Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional. | |
| MX2019000143A (es) | Composiciones, dispositivos y métodos de prueba de sensibilidad a la depresión. | |
| MX2015016721A (es) | Metodo de pronostico en cancer de mama. | |
| Uhm et al. | The risk factors for IgG hypogammaglobulinemia after allogeneic hematopoietic stem cell transplantation and its impact on transplant outcomes | |
| Suzuki et al. | Clinical significance of granules in cytoplasm of newly diagnosed myeloma cells | |
| Martin et al. | PT430 Involvement of Th17 cytokines in acute rheumatic fever |